In clear cell renal cell cancer (ccRCC), these pathways are constitutively active because of loss-of-function mutations of the VHL tumor suppressor gene, which forms part of the E3 ligase central to regulation of HIF (Maxwell et al., 1999). The gene discussed is VHL; the disease is neoplasm.